← Back to Search

Avoiding Coffee for Atrial Fibrillation (DECAF Trial)

N/A

Recruiting

Led By Chris Wong, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Sustained AF

Men and women ≥ 21 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

DECAF Trial Summary

This trial will study the effect of coffee on Atrial Fibrillation recurrence.

Who is the study for?

This trial is for men and women over 21 who have atrial fibrillation, drink coffee daily, and are scheduled for electrical cardioversion. They must be willing to either abstain from or continue drinking coffee and attend follow-up calls. Exclusions include allergies to coffee, recent heart surgeries, pregnancy plans within six months, or participation in conflicting studies.Check my eligibility

What is being tested?

The study tests the impact of coffee on atrial fibrillation by randomly assigning participants to two groups: one that avoids coffee and another that continues consumption post-electrical cardioversion. The goal is to see if avoiding or consuming coffee affects AF recurrence over a six-month period.See study design

What are the potential side effects?

Since this trial involves lifestyle changes rather than medication, side effects may not be as pronounced but could include withdrawal symptoms like headaches or irritability for those stopping coffee.

DECAF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have ongoing atrial fibrillation.

Select...

I am 21 years old or older.

Select...

I am scheduled for a procedure to correct my heart rhythm.

DECAF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants with Recurrent AF or AFlutter (Atrial Flutter)

Rate of AF or AFlutter Recurrence

Secondary outcome measures

Other arrhythmia onset or recurrence

Severity in AF Symptoms

DECAF Trial Design

2Treatment groups

Experimental Treatment

Group I: ConsumeExperimental Treatment1 Intervention

Patients will undergo this intervention for up to 6 months, or whenever their AF returns, whichever comes first.

Group II: AvoidExperimental Treatment1 Intervention

Patients will undergo this intervention for up to 6 months, or whenever their AF returns, whichever comes first.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,355 Total Patients Enrolled

11 Trials studying Atrial Fibrillation

18,924 Patients Enrolled for Atrial Fibrillation

Chris Wong, MDPrincipal InvestigatorUniversity of California, San Francisco

Greg Marcus, MDPrincipal InvestigatorUniversity of California, San Francisco

1 Previous Clinical Trials

301 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open at this time for the research project?

"As referenced on clinicaltrials.gov, this particular medical trial is enrolling participants right now. It was initially posted to the site in October 2021 and subsequently updated February 2022."

Answered by AI

What is the scope of participants in this clinical inquiry?

"Indeed, the information on clinicaltrials.gov declares that recruitment for this medical trial is ongoing. This research effort was first posted on October 20th 2021 and has been revised as of February 22nd 2022 with a requirement to find 200 patients at one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Does Eliminating Coffee Avoid Fibrillation?

2021. "Does Eliminating Coffee Avoid Fibrillation?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05121519.

All > Afib > Atrial Fibrillation